| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/10/2002 | EP1194410A1 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 04/10/2002 | EP1194409A1 Pyrazolidinol compounds |
| 04/10/2002 | EP1194400A1 2-aminoindane analogs |
| 04/10/2002 | EP1194187A1 Antibody-based treatment for streptococcus pneumoniae infection |
| 04/10/2002 | EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 04/10/2002 | EP1194164A1 Prion protein peptides and uses thereof |
| 04/10/2002 | EP1194157A1 D-form polypeptide which induces immune tolerance and methods of use |
| 04/10/2002 | EP1194138A1 Nutritional supplements |
| 04/10/2002 | EP1194132A2 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 04/10/2002 | EP1194044A1 Novel pharmaceutical or dietetic mushroom-based compositions |
| 04/10/2002 | EP1030845B1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 04/10/2002 | EP1015447B1 Piperidinylmethyloxazolidinone derivative |
| 04/10/2002 | EP0948478B1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO[1,2-g]-CHROM-3-ENE, BENZO[1,2-g]-THIOCHROM-3-ENE AND BENZO[1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY |
| 04/10/2002 | EP0901499B1 Adenosine derivatives |
| 04/10/2002 | EP0771191B1 Immunological activity of rhamnolipids |
| 04/10/2002 | EP0758900B1 Botulinum toxin FOR REDUCTION OF migraine HEADACHE PAIN |
| 04/10/2002 | EP0712402B1 Hydroisoquinoline derivatives |
| 04/10/2002 | CN1344326A Petroviral vectors comprising functional and non-functional splice donor and splce acceptor sites |
| 04/10/2002 | CN1344275A Methods for amyloid removal using anti-amyloid antibodies |
| 04/10/2002 | CN1344274A Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/10/2002 | CN1344267A Substituted 1-(pieridin-4-Yl)-3-(aryl) isothioureas their prepn. and therapeutic application |
| 04/10/2002 | CN1344265A Piperidine, tetrahydropyridine and piperazine derivatives, their prepn. and use |
| 04/10/2002 | CN1344264A Tetrahydropyran derivatives and their use as therapeutic agents |
| 04/10/2002 | CN1344249A 酰胺衍生物 Amide derivatives |
| 04/10/2002 | CN1344245A Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy |
| 04/10/2002 | CN1344161A Use of pyridazino [4,5-i(b)]indole-1-acetamide derivatives for preparing medicines for treating disease related to dysfunction of peripheral benzodiazepin receptors |
| 04/10/2002 | CN1344157A Use of certain offinity NMDA antagonists as antidepressants |
| 04/10/2002 | CN1344155A Transnasal transport/immunisation with highly adaptable carriers |
| 04/10/2002 | CN1343724A GDNF mutant and its medical application |
| 04/10/2002 | CN1343689A Short-chain neurotoxin of sea serpent and gene for coding it |
| 04/10/2002 | CN1343515A Areca for giving up smoking and its preparing process |
| 04/10/2002 | CN1343509A Drug-dropping snuff as Chinese medicine |
| 04/09/2002 | US6369228 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain |
| 04/09/2002 | US6369224 Spiroazabicyclic heterocyclic amine borane complexes; psychological, nervous system and brain disorders; anxiolytic agents, antidepressants, analgesics; alzheimer*s and parkinson*s disease; smoking cessationa |
| 04/09/2002 | US6369222 mGluR antagonists and a method for their synthesis |
| 04/09/2002 | US6369221 Anticonvulsants, antiischemic agents; brain and nervous system disorder treatment |
| 04/09/2002 | US6369210 22012, human carboxypeptidase |
| 04/09/2002 | US6369193 Contulakin-G, analogs thereof and uses therefor |
| 04/09/2002 | US6369113 Antidepressants, parkinson's disease |
| 04/09/2002 | US6369099 Method of locking 1 α-OH of vitamin D compounds in axial orientation |
| 04/09/2002 | US6369094 3-(n-methyl-2(r)-pyrrolidinylmethyl)-5-(2-phenylsulphonylethyl )-1h-indole, analgesic for migrane |
| 04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
| 04/09/2002 | US6369084 Prostaglandin mediated diseases |
| 04/09/2002 | US6369082 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 04/09/2002 | US6369079 Methods for treating irritable bowel syndrome using optically pure (+) norcisapride |
| 04/09/2002 | US6369076 Analgesics |
| 04/09/2002 | US6369061 4-bromo-6-(3-(4-chlorophenyl)propoxy)-5-(3-pyridylmethylamino) -3(2h)-pyridazinone |
| 04/09/2002 | US6369060 Central nervous system disorders such as anxiety; 5-methyl-6-trifluoromethyl-1-(6-(2-methylpyridin-3-yloxy)-pyridin-3-yl carbamoyl)indoline and 5-methyl-1-(6-(2-methylpyridin-3-yloxy) -pyridazin-3-ylcarbamoyl)-6-trifluoromethylindoline |
| 04/09/2002 | US6369053 2-Aminoquinolinecarboxamides: neurokinin receptor ligands |
| 04/09/2002 | US6369052 Reverse neuronal dysfunction; alzheimer's; parkinson's disease; amyotrophic lateral sclerosis; strokes; spinal-cord and peripheral nerve injuries; transdermal patch. |
| 04/09/2002 | US6369046 Administration of a glucocorticoid receptor antagonist, mifepristone |
| 04/09/2002 | US6369033 For therapy of multiple sclerosis |
| 04/09/2002 | US6368816 11-beta-reductase inhibitor such as carbenoxolone to control 11-keto steroid conversion to 11-beta-hydroxysteroid; antidiabetic agents |
| 04/09/2002 | US6368797 Determining the genotype at nucleotide 192 of a gene that is an indicator of an increased risk for alzheimer's disease by performing restriction enzyme digestion of an amplified product of the nucleic acid molecule |
| 04/09/2002 | US6368787 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 04/09/2002 | US6368627 Compositions |
| 04/09/2002 | US6368626 Semipermeable wall |
| 04/09/2002 | CA2189731C New 1,4-oxazine tetracyclic compounds, process for preparing the same and pharmceutical compositions containing them |
| 04/09/2002 | CA2141691C Solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 04/09/2002 | CA2120229C Methylpiperazinoazepine derivatives, their preparation and their use |
| 04/09/2002 | CA2090321C Therapeutically useful 2-aminotetralin derivatives |
| 04/09/2002 | CA2033823C Combination of gla or dgla and selenium in psychiatric disorder treatment |
| 04/04/2002 | WO2002027318A1 Methods and compositions for screening modulators of lipid kinases |
| 04/04/2002 | WO2002026998A2 Hydrolases |
| 04/04/2002 | WO2002026996A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 04/04/2002 | WO2002026984A2 Potassium channel interactors and uses therefor |
| 04/04/2002 | WO2002026982A2 Secreted human proteins |
| 04/04/2002 | WO2002026977A1 Host cell obtained by transferring vhl gene into cancer cell or embryonic stem cell and expressing |
| 04/04/2002 | WO2002026976A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility |
| 04/04/2002 | WO2002026950A2 Transferases |
| 04/04/2002 | WO2002026947A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 04/04/2002 | WO2002026946A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 04/04/2002 | WO2002026941A2 Primitive neural stem cells and method for differentiation of stem cells to neural cells |
| 04/04/2002 | WO2002026833A1 Compositions and methods for the endocytic presentation of immunosuppressive factors |
| 04/04/2002 | WO2002026825A2 G-protein coupled receptors |
| 04/04/2002 | WO2002026820A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 04/04/2002 | WO2002026781A2 Ige receptor antagonists |
| 04/04/2002 | WO2002026774A2 Melanocortin receptor ligands |
| 04/04/2002 | WO2002026747A1 Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-a]pyrimidine derivatives with 5-ht receptor affinity |
| 04/04/2002 | WO2002026741A1 1,2,5,10-TETRAHYDROPYRIDAZINO[4,5-b]QUINOLINE-1,10-DIONES AND THEIR USE FOR THE TREATMENT OF PAIN |
| 04/04/2002 | WO2002026740A1 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione and the use thereof for the treatment of pain |
| 04/04/2002 | WO2002026739A1 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
| 04/04/2002 | WO2002026738A1 1,2,5,10-TETRAHYDROPYRIDAZINO[4,5-b]QUINOLINE-1,10-DIONES AND THEIR USE FOR THE TREATMENT OF PAIN |
| 04/04/2002 | WO2002026733A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES |
| 04/04/2002 | WO2002026729A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 04/04/2002 | WO2002026727A2 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | WO2002026724A1 Cyclized benzamide neurokinin antagonists for use in therapy |
| 04/04/2002 | WO2002026723A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026722A1 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026714A1 Spiro compounds |
| 04/04/2002 | WO2002026711A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases |
| 04/04/2002 | WO2002026709A1 Process for producing multiform crystal of donepezil hydrochloride |
| 04/04/2002 | WO2002026694A1 O-substituted 6-methyl-tramadol derivatives |
| 04/04/2002 | WO2002026258A2 Treatment of immune-mediated diseases by oral administration of plasma fractions |
| 04/04/2002 | WO2002026256A1 Excessive antibody production inhibitors, process for producing the same and method of using the same |
| 04/04/2002 | WO2002026245A2 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions |
| 04/04/2002 | WO2002026244A2 Compositions and methods of use for extracts of rutaceae plants |
| 04/04/2002 | WO2002026232A1 Pharmaceutical composition for transmucosal delivery of a dihydroergotamine/metoclopramide combination |
| 04/04/2002 | WO2002026223A2 Catecholamine pharmaceutical compositions and methods |
| 04/04/2002 | WO2002026216A1 Pharmaceutical oxan preparation |